{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T21:55:01Z","timestamp":1778622901089,"version":"3.51.4"},"reference-count":20,"publisher":"Veterinary World","issue":"5","license":[{"start":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T00:00:00Z","timestamp":1526688000000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T00:00:00Z","timestamp":1526688000000},"content-version":"am","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T00:00:00Z","timestamp":1526688000000},"content-version":"tdm","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vet World"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.14202\/vetworld.2018.649-656","type":"journal-article","created":{"date-parts":[[2018,5,19]],"date-time":"2018-05-19T12:52:32Z","timestamp":1526734352000},"page":"649-656","source":"Crossref","is-referenced-by-count":8,"title":["Effects of intratesticular injection of zinc-based solution in rats in combination with anti-inflammatory and analgesic drugs during chemical sterilization"],"prefix":"10.14202","volume":"11","author":[{"given":"Simone Regina Barros","family":"de Macedo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luiz Andre Rodrigues","family":"de Lima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra Maria","family":"de Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinicius Vasconcelos Gomes","family":"de Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosana Nogueira","family":"de Morais","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina Alves","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno Mendes","family":"Tenorio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valdemiro Amaro","family":"da Silva Junior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5308","published-online":{"date-parts":[[2018,5,19]]},"reference":[{"key":"ref0","unstructured":"1. Howlader N, Noone AM, Krapcho M, Miller D, Bishop K, Altekruse SF, Kosary CL, et al. (eds). SEER Cancer Statistics Review, 1975-2013, National Cancer Institute. Bethesda, MD, http:\/\/seer.cancer.gov\/csr\/1975_2013\/, based on November 2015 SEER data submission, posted to the SEER web site, April 2016."},{"issue":"6","key":"ref1","doi-asserted-by":"publisher","first-page":"2962","DOI":"10.1182\/blood-2007-10-078022","article-title":"Multiple myeloma","volume":"111","author":"RA","year":"2008","unstructured":"2. Kyle RA, Rajkumar SV. Multiple myeloma. Blood. 2008;111(6):2962-2972.","journal-title":"Blood"},{"issue":"2","key":"ref2","doi-asserted-by":"publisher","first-page":"102","DOI":"10.3816\/CLM.2005.n.036","article-title":"Monoclonal gammopathy of undetermined significance","volume":"6","author":"RA","year":"2005","unstructured":"3. Kyle RA, Rajkumar SV. Monoclonal gammopathy of undetermined significance. Clin Lymphoma Myeloma. 2005;6(2):102-114.","journal-title":"Clin Lymphoma Myeloma"},{"issue":"25","key":"ref3","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1056\/NEJMoa070389","article-title":"Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma","volume":"356","author":"Kyle","year":"2007","unstructured":"4. Kyle RA, Remstein ED, Therneau TM, Dispenzieri A, Kurtin PJ, Hodnefield JM, Larson DR, et al. Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma. N Engl J Med. 2007;356(25):2582-2590.","journal-title":"N Engl J Med"},{"issue":"1","key":"ref4","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.mayocp.2015.11.007","article-title":"Multiple myeloma: diagnosis and treatment","volume":"91","author":"SV","year":"2016","unstructured":"5. Rajkumar SV, Kumar S. Multiple myeloma: diagnosis and treatment. Mayo Clin Proc. 2016;91(1):101-119.","journal-title":"Mayo Clin Proc"},{"issue":"22","key":"ref5","doi-asserted-by":"publisher","first-page":"5428","DOI":"10.1158\/1078-0432.CCR-16-0866","article-title":"New developments in diagnosis, prognosis, and assessment of response in multiple myeloma","volume":"22","author":"Landgren","year":"2016","unstructured":"6. Landgren O, Rajkumar SV. New developments in diagnosis, prognosis, and assessment of response in multiple myeloma. Clin Cancer Res. 2016;22(22):5428-5433.","journal-title":"Clin Cancer Res"},{"issue":"8","key":"ref6","doi-asserted-by":"publisher","first-page":"e328","DOI":"10.1016\/S1470-2045(16)30206-6","article-title":"International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.","volume":"17","author":"Kumar","year":"2016","unstructured":"7. Kumar S, Paiva B, Anderson KC, Durie B, Landgren O, Moreau P, Munshi N, et al. International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma. Lancet Oncol. 2016;17(8):e328-e346.","journal-title":"Lancet Oncol","ISSN":"https:\/\/id.crossref.org\/issn\/1470-2045","issn-type":"print"},{"issue":"18","key":"ref7","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1182\/blood-2010-10-299529","article-title":"Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3","volume":"117","author":"Dimopoulos","year":"2011","unstructured":"8. Dimopoulos M, Kyle R, Fermand JP, Rajkumar SV, San Miguel J, Chanan-Khan A, Ludwig H, et al. Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3. Blood. 2011;117(18):4701-4705.","journal-title":"Blood"},{"key":"ref8","volume-title":"Serum Free Light Chain Analysis plus Hevylite","author":"Bradwell","year":"2015","unstructured":"9. Bradwell A. Serum Free Light Chain Analysis plus Hevylite, 7 ed. Birmingham, UK: The Binding Site Group Ltd. 2015."},{"issue":"2","key":"ref9","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/ajcp\/aqw099","article-title":"Serum free light chain assay and kappa\/lambda ratio performance in patients without monoclonal gammopathies: high false-positive rate","volume":"146","author":"Singh","year":"2016","unstructured":"10. Singh G. Serum free light chain assay and kappa\/lambda ratio performance in patients without monoclonal gammopathies: high false-positive rate. Am J Clin Pathol. 2016;146(2):207-214.","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"ref10","doi-asserted-by":"publisher","first-page":"46","DOI":"10.14740\/jocmr2802w","article-title":"Serum free light chain assay and kappa\/lambda ratio: performance in patients with monoclonal gammopathy-high false negative rate for kappa\/lambda ratio","volume":"9","author":"Singh","year":"2017","unstructured":"11. Singh G. Serum free light chain assay and kappa\/lambda ratio: performance in patients with monoclonal gammopathy-high false negative rate for kappa\/lambda ratio. J Clin Med Res. 2017;9(1):46-57.","journal-title":"J Clin Med Res"},{"key":"ref11","unstructured":"4. Rao M, Lamont J, Chan J, et al. Effective health care program. Future research needs paper number 23. Serum free light chain analysis for the diagnosis, management, and prognosis of plasma cell dyscrasias: future research needs. AHRQ Publication No. 12-EHC135-EF. 2012."},{"issue":"3","key":"ref12","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/S1092-9134(00)90042-X","article-title":"Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory","volume":"4","author":"Herrera","year":"2000","unstructured":"13. Herrera GA. Renal manifestations of plasma cell dyscrasias: an appraisal from the patients' bedside to the research laboratory. Ann Diagn Pathol. 2000;4(3):174-200.","journal-title":"Ann Diagn Pathol"},{"issue":"9","key":"ref13","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1093\/clinchem\/48.9.1437","article-title":"Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains.","volume":"48","author":"Katzmann","year":"2002","unstructured":"14. Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA. Serum reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains: relative sensitivity for detection of monoclonal light chains. Clin Chem. 2002;48(9):1437-1444.","journal-title":"Clin Chem","ISSN":"https:\/\/id.crossref.org\/issn\/0009-9147","issn-type":"print"},{"issue":"8","key":"ref14","doi-asserted-by":"publisher","first-page":"671","DOI":"10.14740\/jocmr3049w","article-title":"Oligoclonal pattern\/abnormal protein bands in post-treatment plasma cell myeloma patients: implications for protein electrophoresis and serum free light chain assay results","volume":"9","author":"Singh","year":"2017","unstructured":"15. Singh G. Oligoclonal pattern\/abnormal protein bands in post-treatment plasma cell myeloma patients: implications for protein electrophoresis and serum free light chain assay results. J Clin Med Res. 2017;9(8):671-679.","journal-title":"J Clin Med Res"},{"issue":"8","key":"ref15","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1373\/clinchem.2009.126664","article-title":"Screening panels for detection of monoclonal gammopathies","volume":"55","author":"Katzmann","year":"2009","unstructured":"16. Katzmann JA, Kyle RA, Benson J, Larson DR, Snyder MR, Lust JA, Rajkumar SV, et al. Screening panels for detection of monoclonal gammopathies. Clin Chem. 2009;55(8):1517-1522.","journal-title":"Clin Chem"},{"issue":"12","key":"ref16","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.4065\/81.12.1575","article-title":"Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays","volume":"81","author":"Katzmann","year":"2006","unstructured":"17. Katzmann JA, Dispenzieri A, Kyle RA, Snyder MR, Plevak MF, Larson DR, Abraham RS, et al. Elimination of the need for urine studies in the screening algorithm for monoclonal gammopathies by using serum immunofixation and free light chain assays. Mayo Clin Proc. 2006;81(12):1575-1578.","journal-title":"Mayo Clin Proc"},{"key":"ref17","volume-title":"The generation of diversity in immunoglobulins Immunobiology the immune system in health and disease","author":"Janeway","year":"2001","unstructured":"18. Janeway CA Jr, Travers P, Walport M. The generation of diversity in immunoglobulins. Immunobiology; the immune system in health and disease. New York Garland Science. 2001."},{"issue":"3","key":"ref18","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1046\/j.1365-2567.2004.01902.x","article-title":"Insights into the regulation of immunoglobulin light chain gene rearrangements via analysis of the kappa light chain locus in lambda myeloma","volume":"112","author":"Perfetti","year":"2004","unstructured":"19. Perfetti V, Vignarelli MC, Palladini G, Navazza V, Giachino C, Merlini G. Insights into the regulation of immunoglobulin light chain gene rearrangements via analysis of the kappa light chain locus in lambda myeloma. Immunology. 2004;112(3):420-427.","journal-title":"Immunology"},{"issue":"25","key":"ref19","doi-asserted-by":"publisher","first-page":"2941","DOI":"10.1182\/blood-2016-07-726778","article-title":"Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma","volume":"128","author":"Dejoie","year":"2016","unstructured":"20. Dejoie T, Corre J, Caillon H, Hulin C, Perrot A, Caillot D, Boyle E, et al. Serum free light chains, not urine specimens, should be used to evaluate response in light-chain multiple myeloma. Blood. 2016;128(25):2941-2948.","journal-title":"Blood"}],"container-title":["Veterinary World"],"original-title":[],"link":[{"URL":"http:\/\/www.veterinaryworld.org\/Vol.11\/May-2018\/12.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.veterinaryworld.org\/Vol.11\/May-2018\/12.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"text-mining"},{"URL":"http:\/\/www.veterinaryworld.org\/Vol.11\/May-2018\/12.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,22]],"date-time":"2020-11-22T07:59:38Z","timestamp":1606031978000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.veterinaryworld.org\/Vol.11\/May-2018\/12.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":20,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2018,5,19]]},"published-print":{"date-parts":[[2018,5]]}},"URL":"https:\/\/doi.org\/10.14202\/vetworld.2018.649-656","relation":{},"ISSN":["0972-8988","2231-0916"],"issn-type":[{"value":"0972-8988","type":"print"},{"value":"2231-0916","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}